on the basis of these findings , it is suggested that screening for malignant hyperpyrexia by in vitro pharmacological testing of skeletal muscle should be carried out at 37 degrees c , and should include exposure of the sample to halothane , caffeine , suxamethonium and potassium rather than to halothane alone .
C0024591
malignant hyperpyrexia
C0038627
suxamethonium